Literature DB >> 7843595

Hamster Greene melanoma in the rabbit eye: immunosuppressive treatment to improve this tumor model.

I de Waard-Siebinga1, J L van Delft, D de Wolff-Rouendaal, M Jager.   

Abstract

BACKGROUND: The hamster Greene melanoma (HGM) implanted in the anterior chamber of the rabbit eye has been used to study experimental therapies for human uveal melanoma. However, the occurrence of spontaneous necrosis limits the value of this model for long-term evaluation of experimental treatments. In the present study we tested the hypothesis that an immune response is the cause of this necrosis and that prevention of the immune response can prolong the experimentation time
METHODS: HGM was implanted in the anterior chamber of control, presensitized and immunosuppressed rabbits. The effects of sensitization and immunosuppression were assessed by clinical and histological observation
RESULTS: Sensitization led to a significant slowing down of tumor growth, but not to a difference in necrosis. Immunosuppressive treatment with cyclosporin A improved the success rate of implantation and decreased the amount of necrosis in the tumor
CONCLUSION: The immune response plays a role in the occurrence of necrosis. However, although immunosuppressive treatment with cyclosporin A decreased the amount of necrosis, significant necrosis still occurred, suggesting that other factors like angiogenesis play a part as well and still limit the usefulness of this model in the long-term evaluation of experimental therapies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7843595     DOI: 10.1007/bf00171385

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  17 in total

1.  Heterologous transplantation of the Brown-Pearce tumors.

Authors:  H S N GREENE
Journal:  Cancer Res       Date:  1949-12       Impact factor: 12.701

Review 2.  Immune privilege and immune regulation in the eye.

Authors:  J Y Niederkorn
Journal:  Adv Immunol       Date:  1990       Impact factor: 3.543

Review 3.  Immune regulation and the eye: a dangerous compromise.

Authors:  J W Streilein
Journal:  FASEB J       Date:  1987-09       Impact factor: 5.191

4.  Anterior chamber associated immune deviation induced by TNP-splenocytes (TNP-ACAID). I. Systemic tolerance mediated by suppressor T-cells.

Authors:  J C Waldrep; H J Kaplan
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-08       Impact factor: 4.799

5.  Penetrating keratoplasty in the rat: a model for the study of immunosuppressive treatment of graft rejection.

Authors:  C P Herbort; M Matsubara; M Nishi; M Mochizuki
Journal:  Jpn J Ophthalmol       Date:  1989       Impact factor: 2.447

6.  Hamster Greene melanoma implanted in the anterior chamber of a rabbit eye: a reliable tumor model?

Authors:  T J Römer; J L van Delft; D de Wolff-Rouendaal; M J Jager
Journal:  Ophthalmic Res       Date:  1992       Impact factor: 2.892

7.  Suppression of corneal neovascularization with cyclosporine.

Authors:  R M Lipman; R J Epstein; R L Hendricks
Journal:  Arch Ophthalmol       Date:  1992-03

8.  The effects of ultrasonically induced hyperthermia on experimental tumors in the rabbit eye.

Authors:  R Braakman; P van der Valk; J L van Delft; D de Wolff-Rouendaal; J A Oosterhuis
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-05       Impact factor: 4.799

9.  Hematoporphyrin derivative photoradiation treatment of experimental malignant melanoma in the anterior chamber of the rabbit.

Authors:  K A Franken; J L van Delft; T M Dubbelman; D de Wolff-Rouendaal; J A Oosterhuis; W M Star; H P Marijnissen
Journal:  Curr Eye Res       Date:  1985-05       Impact factor: 2.424

10.  Anterior chamber-associated immune deviation induced by TNP-splenocytes (TNP-ACAID). II. Suppressor T-cell networks.

Authors:  J C Waldrep; H J Kaplan
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-10       Impact factor: 4.799

View more
  3 in total

Review 1.  Animal Eye Models for Uveal Melanoma.

Authors:  Jinfeng Cao; Martine J Jager
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

2.  Animal Models of Uveal Melanoma.

Authors:  Ogul E Uner; Nikhila Gandrakota; Corrina P Azarcon; Hans E Grossniklaus
Journal:  Ann Eye Sci       Date:  2022-03-15

3.  The Anterior Eye Chamber as a Visible Medium for In Vivo Tumorigenicity Tests.

Authors:  Emi Inagaki; Eri Arai; Shin Hatou; Tomoko Sayano; Hiroko Taniguchi; Kazuno Negishi; Yae Kanai; Yasunori Sato; Hideyuki Okano; Kazuo Tsubota; Shigeto Shimmura
Journal:  Stem Cells Transl Med       Date:  2022-08-23       Impact factor: 7.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.